Improving cancer dose-response characterization by using physiologicall based pharmacokinetic modeling : an analysis of pooled data for acrylonitrile-induce brain tumors to asses cancer potency in...

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000nab a2200000 i 4500</leader>
    <controlfield tag="001">MAP20071501032</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20220911212211.0</controlfield>
    <controlfield tag="007">hzruuu---uuuu</controlfield>
    <controlfield tag="008">000906s2000    usa||||    | |00010|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">873</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Improving cancer dose-response characterization by using physiologicall based pharmacokinetic modeling</subfield>
      <subfield code="b">: an analysis of pooled data for acrylonitrile-induce brain tumors to asses cancer potency in the rat.</subfield>
      <subfield code="c">Chirstopher R. Kirman... [et al.] </subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">Methods -- Assessment of cancer potency using EPA's approach -- Assessment of cancer potency by pooling PBPK-Derived dose-response data -- Results -- Standar approach -- Pooled data approach -- Discussion -- References.</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080571566</subfield>
      <subfield code="a">Casos prácticos</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080539771</subfield>
      <subfield code="a">Salud</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080578848</subfield>
      <subfield code="a">Análisis de datos</subfield>
    </datafield>
    <datafield tag="650" ind1="0" ind2="1">
      <subfield code="0">MAPA20080540500</subfield>
      <subfield code="a">Cáncer</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080572181</subfield>
      <subfield code="a">Farmacocinética</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080554392</subfield>
      <subfield code="a">Fisiología</subfield>
    </datafield>
    <datafield tag="650" ind1="0" ind2="1">
      <subfield code="0">MAPA20080576615</subfield>
      <subfield code="a">Medicina laboral</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080553395</subfield>
      <subfield code="a">Bioquímica</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080591960</subfield>
      <subfield code="a">Métodos de análisis</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080071370</subfield>
      <subfield code="a">Hays, Sean M.</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="w">MAP20077000345</subfield>
      <subfield code="t">Risk analysis : an international journal</subfield>
      <subfield code="d">New York and London : Society for Risk Analysis</subfield>
      <subfield code="g">Vol. 20, nº 1, Februaryl, 2000 ; p. 135-151</subfield>
    </datafield>
  </record>
</collection>